| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |